View Future GrowthPolychem 過去の業績この会社の最新の決算報告書はまだ処理中です過去 基準チェック /66Polychemは、平均年間37%の収益成長を遂げていますが、 Chemicals業界の収益は、年間 成長しています。収益は、平均年間6.7% 12%収益成長率で 成長しています。 Polychemの自己資本利益率は59.6%であり、純利益率は25.6%です。主要情報37.03%収益成長率37.03%EPS成長率Chemicals 業界の成長17.68%収益成長率12.04%株主資本利益率59.57%ネット・マージン25.56%前回の決算情報31 Dec 2025最近の業績更新お知らせ • May 14Polychem Limited to Report Q4, 2026 Results on May 21, 2026Polychem Limited announced that they will report Q4, 2026 results on May 21, 2026Reported Earnings • Feb 10Third quarter 2026 earnings released: EPS: ₹338 (vs ₹21.87 in 3Q 2025)Third quarter 2026 results: EPS: ₹338 (up from ₹21.87 in 3Q 2025). Revenue: ₹378.5m (up 262% from 3Q 2025). Net income: ₹136.6m (up ₹127.7m from 3Q 2025). Profit margin: 36% (up from 8.4% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Feb 03Polychem Limited to Report Q3, 2026 Results on Feb 09, 2026Polychem Limited announced that they will report Q3, 2026 results on Feb 09, 2026Reported Earnings • Nov 13Second quarter 2026 earnings released: EPS: ₹17.73 (vs ₹11.45 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹17.73 (up from ₹11.45 loss in 2Q 2025). Revenue: ₹105.7m (up 43% from 2Q 2025). Net income: ₹7.17m (up ₹11.8m from 2Q 2025). Profit margin: 6.8% (up from net loss in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 32% per year, which means it is well ahead of earnings.お知らせ • Nov 05Polychem Limited to Report Q2, 2026 Results on Nov 12, 2025Polychem Limited announced that they will report Q2, 2026 results on Nov 12, 2025お知らせ • Jul 30Polychem Limited to Report Q1, 2026 Results on Aug 06, 2025Polychem Limited announced that they will report Q1, 2026 results on Aug 06, 2025すべての更新を表示Recent updatesお知らせ • May 14Polychem Limited to Report Q4, 2026 Results on May 21, 2026Polychem Limited announced that they will report Q4, 2026 results on May 21, 2026Valuation Update With 7 Day Price Move • Feb 26Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹2,285, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 168% over the past three years.Reported Earnings • Feb 10Third quarter 2026 earnings released: EPS: ₹338 (vs ₹21.87 in 3Q 2025)Third quarter 2026 results: EPS: ₹338 (up from ₹21.87 in 3Q 2025). Revenue: ₹378.5m (up 262% from 3Q 2025). Net income: ₹136.6m (up ₹127.7m from 3Q 2025). Profit margin: 36% (up from 8.4% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Feb 03Polychem Limited to Report Q3, 2026 Results on Feb 09, 2026Polychem Limited announced that they will report Q3, 2026 results on Feb 09, 2026Reported Earnings • Nov 13Second quarter 2026 earnings released: EPS: ₹17.73 (vs ₹11.45 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹17.73 (up from ₹11.45 loss in 2Q 2025). Revenue: ₹105.7m (up 43% from 2Q 2025). Net income: ₹7.17m (up ₹11.8m from 2Q 2025). Profit margin: 6.8% (up from net loss in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 32% per year, which means it is well ahead of earnings.お知らせ • Nov 05Polychem Limited to Report Q2, 2026 Results on Nov 12, 2025Polychem Limited announced that they will report Q2, 2026 results on Nov 12, 2025New Risk • Oct 14New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹885.3m (US$9.97m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹885.3m market cap, or US$9.97m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.3% average weekly change). Large one-off items impacting financial results. Revenue is less than US$5m (₹415m revenue, or US$4.7m).New Risk • Aug 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.1% average weekly change). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (6.8% net profit margin). Revenue is less than US$5m (₹417m revenue, or US$4.8m). Market cap is less than US$100m (₹984.4m market cap, or US$11.3m).お知らせ • Jul 30Polychem Limited to Report Q1, 2026 Results on Aug 06, 2025Polychem Limited announced that they will report Q1, 2026 results on Aug 06, 2025Reported Earnings • Jul 23Full year 2025 earnings released: EPS: ₹70.06 (vs ₹178 in FY 2024)Full year 2025 results: EPS: ₹70.06 (down from ₹178 in FY 2024). Revenue: ₹416.5m (down 23% from FY 2024). Net income: ₹28.3m (down 61% from FY 2024). Profit margin: 6.8% (down from 13% in FY 2024). Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jul 17Polychem Limited, Annual General Meeting, Aug 12, 2025Polychem Limited, Annual General Meeting, Aug 12, 2025, at 11:00 Indian Standard Time.New Risk • Jun 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.9% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (6.8% net profit margin). Revenue is less than US$5m (₹417m revenue, or US$4.9m). Market cap is less than US$100m (₹1.14b market cap, or US$13.3m).Valuation Update With 7 Day Price Move • Jun 26Investor sentiment improves as stock rises 29%After last week's 29% share price gain to ₹2,522, the stock trades at a trailing P/E ratio of 36x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 303% over the past three years.Declared Dividend • Jun 22Dividend reduced to ₹20.00Dividend of ₹20.00 is 33% lower than last year. Ex-date: 1st July 2025 Payment date: 31st July 2025 Dividend yield will be 1.0%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (29% earnings payout ratio) and cash flows (50% cash payout ratio). The dividend has increased by an average of 26% per year over the past 9 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 68% to shift the payout ratio to a potentially unsustainable range, which is more than the 1.6% EPS decline seen over the last 5 years.New Risk • May 22New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 62% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹801.4m market cap, or US$9.36m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (6.8% net profit margin). Revenue is less than US$5m (₹417m revenue, or US$4.9m).Reported Earnings • May 15Full year 2025 earnings released: EPS: ₹70.06 (vs ₹178 in FY 2024)Full year 2025 results: EPS: ₹70.06 (down from ₹178 in FY 2024). Revenue: ₹439.0m (down 19% from FY 2024). Net income: ₹28.3m (down 61% from FY 2024). Profit margin: 6.4% (down from 13% in FY 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • May 10Polychem Limited to Report Q4, 2025 Results on May 14, 2025Polychem Limited announced that they will report Q4, 2025 results on May 14, 2025Board Change • Apr 01Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Director Anand Dalal was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Feb 28Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹1,910, the stock trades at a trailing P/E ratio of 18x. Average trailing P/E is 24x in the Chemicals industry in India. Total returns to shareholders of 228% over the past three years.Buy Or Sell Opportunity • Feb 14Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.1% to ₹2,170. The fair value is estimated to be ₹2,793, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Earnings per share has grown by 35%.Reported Earnings • Feb 13Third quarter 2025 earnings released: EPS: ₹21.87 (vs ₹43.14 in 3Q 2024)Third quarter 2025 results: EPS: ₹21.87 (down from ₹43.14 in 3Q 2024). Revenue: ₹108.3m (down 18% from 3Q 2024). Net income: ₹8.84m (down 49% from 3Q 2024). Profit margin: 8.2% (down from 13% in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth.New Risk • Feb 11New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹853.1m (US$9.84m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Market cap is less than US$10m (₹853.1m market cap, or US$9.84m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.お知らせ • Feb 03Polychem Limited to Report Q3, 2025 Results on Feb 11, 2025Polychem Limited announced that they will report Q3, 2025 results on Feb 11, 2025Valuation Update With 7 Day Price Move • Nov 28Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₹2,525, the stock trades at a trailing P/E ratio of 19.8x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 447% over the past three years.Reported Earnings • Nov 14Second quarter 2025 earnings released: ₹11.45 loss per share (vs ₹37.38 profit in 2Q 2024)Second quarter 2025 results: ₹11.45 loss per share (down from ₹37.38 profit in 2Q 2024). Revenue: ₹81.1m (down 33% from 2Q 2024). Net loss: ₹4.63m (down 131% from profit in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has increased by 67% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Nov 13Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹2,359, the stock trades at a trailing P/E ratio of 13.4x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 391% over the past three years.お知らせ • Nov 06Polychem Limited to Report Q2, 2025 Results on Nov 13, 2024Polychem Limited announced that they will report Q2, 2025 results on Nov 13, 2024Buy Or Sell Opportunity • Oct 08Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 4.7% to ₹3,062. The fair value is estimated to be ₹2,548, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 62%.New Risk • Sep 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.2% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (₹1.24b market cap, or US$14.8m).Valuation Update With 7 Day Price Move • Sep 18Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹3,538, the stock trades at a trailing P/E ratio of 20.1x. Average trailing P/E is 36x in the Chemicals industry in India. Total returns to shareholders of 599% over the past three years.Buy Or Sell Opportunity • Sep 18Now 38% overvalued after recent price riseOver the last 90 days, the stock has risen 24% to ₹3,538. The fair value is estimated to be ₹2,566, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 62%.お知らせ • Aug 29Polychem Limited Approves DividendPolychem Limited at its AGM held on August 29, 2024, approved to declare a dividend of INR 30.00 i.e (300%) per equity share of INR 10.00 each.Reported Earnings • Aug 07Full year 2024 earnings released: EPS: ₹178 (vs ₹179 in FY 2023)Full year 2024 results: EPS: ₹178 (down from ₹179 in FY 2023). Revenue: ₹538.7m (up 5.1% from FY 2023). Net income: ₹72.0m (flat on FY 2023). Profit margin: 13% (in line with FY 2023). Over the last 3 years on average, earnings per share has increased by 71% per year and the company’s share price has also increased by 71% per year.お知らせ • Aug 02+ 1 more updatePolychem Limited, Annual General Meeting, Aug 29, 2024Polychem Limited, Annual General Meeting, Aug 29, 2024, at 11:00 Indian Standard Time.Buy Or Sell Opportunity • Jul 04Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 12% to ₹2,978. The fair value is estimated to be ₹2,466, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 71%.New Risk • Jun 06New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 22% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Market cap is less than US$100m (₹1.12b market cap, or US$13.5m).Buy Or Sell Opportunity • May 31Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 4.3% to ₹2,889. The fair value is estimated to be ₹2,406, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 71%.Buy Or Sell Opportunity • May 15Now 21% overvaluedOver the last 90 days, the stock has fallen 3.0% to ₹2,894. The fair value is estimated to be ₹2,398, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 71%.お知らせ • May 15Polychem Limited Proposes Dividend for the Financial Year Ended March 31, 2024Polychem Limited at its board meeting held on May 14, 2024, proposed payment of dividend of INR 30 per equity share of INR 10 each that is 300% on the Equity shares of the Company for the financial year ended 31st March, 2024, subject to the approval of shareholders at the upcoming Annual General Meeting.お知らせ • May 08Polychem Limited to Report Q4, 2024 Results on May 14, 2024Polychem Limited announced that they will report Q4, 2024 results on May 14, 2024Valuation Update With 7 Day Price Move • Apr 08Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹2,741, the stock trades at a trailing P/E ratio of 16.9x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 505% over the past three years.Valuation Update With 7 Day Price Move • Mar 13Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹2,142, the stock trades at a trailing P/E ratio of 13.2x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 355% over the past three years.Reported Earnings • Feb 10Third quarter 2024 earnings released: EPS: ₹43.14 (vs ₹38.35 in 3Q 2023)Third quarter 2024 results: EPS: ₹43.14 (up from ₹38.35 in 3Q 2023). Revenue: ₹137.5m (up 11% from 3Q 2023). Net income: ₹17.4m (up 13% from 3Q 2023). Profit margin: 13% (in line with 3Q 2023). Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has increased by 90% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Feb 03Polychem Limited to Report Q3, 2024 Results on Feb 09, 2024Polychem Limited announced that they will report Q3, 2024 results on Feb 09, 2024Valuation Update With 7 Day Price Move • Dec 19Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹3,183, the stock trades at a trailing P/E ratio of 19.7x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 714% over the past three years.Reported Earnings • Nov 09Second quarter 2024 earnings released: EPS: ₹37.38 (vs ₹71.44 in 2Q 2023)Second quarter 2024 results: EPS: ₹37.38 (down from ₹71.44 in 2Q 2023). Revenue: ₹124.1m (down 8.9% from 2Q 2023). Net income: ₹15.1m (down 48% from 2Q 2023). Profit margin: 12% (down from 21% in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 75% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 30Polychem Limited Approves to Declare A DividendPolychem Limited approved to declare a dividend of INR 20/- per equity share (i.e. 200%) of INR 10/- each.Reported Earnings • Aug 09First quarter 2024 earnings released: EPS: ₹39.65 (vs ₹23.08 in 1Q 2023)First quarter 2024 results: EPS: ₹39.65 (up from ₹23.08 in 1Q 2023). Revenue: ₹142.4m (up 1.1% from 1Q 2023). Net income: ₹16.0m (up 72% from 1Q 2023). Profit margin: 11% (up from 6.6% in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 77% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth.New Risk • Aug 07New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 102% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹612.8m market cap, or US$7.41m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.7% average weekly change). Large one-off items impacting financial results.お知らせ • Aug 01Polychem Limited to Report Q1, 2024 Results on Aug 08, 2023Polychem Limited announced that they will report Q1, 2024 results on Aug 08, 2023Valuation Update With 7 Day Price Move • Jun 30Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹1,335, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 240% over the past three years.New Risk • Jun 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹510.8m market cap, or US$6.22m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.3% average weekly change).Reported Earnings • May 19Full year 2023 earnings released: EPS: ₹179 (vs ₹12.53 in FY 2022)Full year 2023 results: EPS: ₹179 (up from ₹12.53 in FY 2022). Revenue: ₹568.5m (up 59% from FY 2022). Net income: ₹72.3m (up ₹67.2m from FY 2022). Profit margin: 13% (up from 1.4% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has increased by 67% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • May 18Polychem Limited Recommends Dividend for the Financial Year Ended 31 March 2023The board of directors of Polychem Limited at its meeting held on May 17, 2023, Payment of dividend of INR 20 per share of INR 10 each i.e 200% on the Equity shares of the Company for the financial year ended 31 March, 2023, subject to the approval of shareholders at the upcoming Annual General Meeting.お知らせ • May 11Polychem Limited to Report Q4, 2023 Results on May 17, 2023Polychem Limited announced that they will report Q4, 2023 results on May 17, 2023Valuation Update With 7 Day Price Move • May 11Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹1,123, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 292% over the past three years.Valuation Update With 7 Day Price Move • Feb 15Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹977, the stock trades at a trailing P/E ratio of 6.5x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 126% over the past three years.Buying Opportunity • Feb 14Now 20% undervaluedOver the last 90 days, the stock is up 3.5%. The fair value is estimated to be ₹1,228, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 17%.Reported Earnings • Feb 09Third quarter 2023 earnings released: EPS: ₹38.35 (vs ₹4.37 loss in 3Q 2022)Third quarter 2023 results: EPS: ₹38.35 (up from ₹4.37 loss in 3Q 2022). Revenue: ₹127.7m (up 46% from 3Q 2022). Net income: ₹15.5m (up ₹17.3m from 3Q 2022). Profit margin: 12% (up from net loss in 3Q 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Feb 01Polychem Limited to Report Q3, 2023 Results on Feb 08, 2023Polychem Limited announced that they will report Q3, 2023 results on Feb 08, 2023Reported Earnings • Nov 20Second quarter 2023 earnings released: EPS: ₹71.44 (vs ₹3.70 loss in 2Q 2022)Second quarter 2023 results: EPS: ₹71.44 (up from ₹3.70 loss in 2Q 2022). Revenue: ₹171.8m (up 108% from 2Q 2022). Net income: ₹28.9m (up ₹30.4m from 2Q 2022). Profit margin: 17% (up from net loss in 2Q 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 43% per year, which means it is well ahead of earnings.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 6 highly experienced directors. Woman Independent Non Executive Director Nirmala Mehendale was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Nov 05Polychem Limited to Report Q2, 2023 Results on Nov 14, 2022Polychem Limited announced that they will report Q2, 2023 results on Nov 14, 2022お知らせ • Aug 31Polychem Limited Declares DividendPolychem Limited at its AGM held on 29 August 2022 declared a dividend of INR 3/- per equity share of INR 10/- each (i.e. 30%).Valuation Update With 7 Day Price Move • Aug 30Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹969, the stock trades at a trailing P/E ratio of 33.6x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 241% over the past three years.Valuation Update With 7 Day Price Move • Aug 16Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹737, the stock trades at a trailing P/E ratio of 25.6x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 145% over the past three years.Reported Earnings • Aug 04Full year 2022 earnings released: EPS: ₹12.53 (vs ₹20.48 in FY 2021)Full year 2022 results: EPS: ₹12.53 (down from ₹20.48 in FY 2021). Revenue: ₹357.8m (up 45% from FY 2021). Net income: ₹5.06m (down 39% from FY 2021). Profit margin: 1.4% (down from 3.4% in FY 2021). Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 23% per year, which means it is well ahead of earnings.お知らせ • Aug 04Polychem Limited, Annual General Meeting, Aug 29, 2022Polychem Limited, Annual General Meeting, Aug 29, 2022, at 11:00 Indian Standard Time. Agenda: To consider the audited Standalone financial statements of the Company for the financial year ended March 31, 2022, including the audited Standalone Balance Sheet as at March 31, 2022, the Statement of Profit and Loss and Cash Flow Statement, for the year ended on that date and the reports of the Board of Directors (the Board) and Auditors thereon; to discuss the audited consolidated financial statements of the Company for the financial year ended March 31, 2022, including the audited Consolidated Balance Sheet as at March 31, 2022, the Statement of Profit and Loss and Cash Flow Statement for the year ended on that date and the report of Auditors thereon; to declare dividend on equity shares; to reappoint statutory auditors; and to discuss other matters.Valuation Update With 7 Day Price Move • Jun 27Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹640, the stock trades at a trailing P/E ratio of 51.1x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 140% over the past three years.Valuation Update With 7 Day Price Move • Jun 07Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₹653, the stock trades at a trailing P/E ratio of 52.1x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 120% over the past three years.お知らせ • May 27Polychem Limited Recommends DividendPolychem Limited announced Payment of dividend of INR 3.00 per share of INR 10 each i.e 30% on the Equity shares of the Company for the financial year ended 31st March, 2022, subject to the approval of shareholders at the ensuing 65th AGM.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 5 highly experienced directors. Woman Independent Non Executive Director Nirmala Mehendale was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Apr 18Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹709, the stock trades at a trailing P/E ratio of 77.9x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 151% over the past three years.Reported Earnings • Feb 16Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: ₹4.37 loss per share (down from ₹13.94 profit in 3Q 2021). Revenue: ₹89.1m (up 29% from 3Q 2021). Net loss: ₹1.77m (down 131% from profit in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 31% per year, which means it is well ahead of earnings.お知らせ • Feb 06Polychem Limited to Report Q3, 2022 Results on Feb 14, 2022Polychem Limited announced that they will report Q3, 2022 results on Feb 14, 2022Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹555, the stock trades at a trailing P/E ratio of 20.2x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 49% over the past three years.Reported Earnings • Jun 26Full year 2021 earnings released: EPS ₹20.48 (vs ₹75.89 in FY 2020)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹260.6m (down 29% from FY 2020). Net income: ₹8.27m (down 73% from FY 2020). Profit margin: 3.2% (down from 8.3% in FY 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 33% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Jun 24Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹802, the stock trades at a trailing P/E ratio of 32.7x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 183% over the past three years.Valuation Update With 7 Day Price Move • Jun 05Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₹575, the stock trades at a trailing P/E ratio of 23.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 63% over the past three years.Is New 90 Day High Low • Mar 10New 90-day high: ₹493The company is up 13% from its price of ₹437 on 10 December 2020. The Indian market is up 14% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Chemicals industry, which is up 9.0% over the same period.Is New 90 Day High Low • Feb 11New 90-day high: ₹480The company is up 9.0% from its price of ₹440 on 13 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 16% over the same period.Reported Earnings • Feb 06Third quarter 2021 earnings released: EPS ₹13.94 (vs ₹22.35 in 3Q 2020)The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹74.1m (down 14% from 3Q 2020). Net income: ₹5.63m (down 38% from 3Q 2020). Profit margin: 7.6% (down from 10% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.お知らせ • Jan 25Polychem Limited to Report Q3, 2021 Results on Feb 05, 2021Polychem Limited announced that they will report Q3, 2021 results on Feb 05, 2021Is New 90 Day High Low • Nov 17New 90-day low: ₹424The company is down 31% from its price of ₹616 on 19 August 2020. The Indian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period.Valuation Update With 7 Day Price Move • Nov 06Market pulls back on stock over the past weekAfter last week's 16% share price decline to ₹475, the stock is trading at a trailing P/E ratio of 9.4x, down from the previous P/E ratio of 11.3x. This compares to an average P/E of 16x in the Chemicals industry in India. Total returns to shareholders over the past three years are 19%.お知らせ • Jul 09Polychem Limited to Report Q4, 2020 Results on Jul 11, 2020Polychem Limited announced that they will report Q4, 2020 results on Jul 11, 2020収支内訳Polychem の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史BSE:506605 収益、費用、利益 ( )INR Millions日付収益収益G+A経費研究開発費31 Dec 2573018776030 Sep 254425974030 Jun 254154773031 Mar 254172872031 Dec 244594370030 Sep 244875174030 Jun 245337170031 Mar 245397271031 Dec 235026673030 Sep 234936570030 Jun 235097969031 Mar 235127268031 Dec 225126166030 Sep 224764264030 Jun 224221264031 Mar 22358562031 Dec 21337459030 Sep 213191159030 Jun 212951356031 Mar 21246856031 Dec 202461058030 Sep 202641358030 Jun 203012059031 Mar 203693160031 Dec 193693360030 Sep 193863259030 Jun 194013757031 Mar 194163656031 Mar 18308248031 Mar 17267844031 Mar 16123323031 Dec 15118136030 Sep 15120136030 Jun 151374380質の高い収益: 506605は 高品質の収益 を持っています。利益率の向上: 506605の現在の純利益率 (25.6%)は、昨年(9.3%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 506605の収益は過去 5 年間で年間37%増加しました。成長の加速: 506605の過去 1 年間の収益成長率 ( 335.7% ) は、5 年間の平均 ( 年間37%を上回っています。収益対業界: 506605の過去 1 年間の収益成長率 ( 335.7% ) はChemicals業界10.1%を上回りました。株主資本利益率高いROE: 506605の 自己資本利益率 ( 59.6% ) は 傑出している と考えられます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 18:43終値2026/05/22 00:00収益2025/12/31年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Polychem Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 14Polychem Limited to Report Q4, 2026 Results on May 21, 2026Polychem Limited announced that they will report Q4, 2026 results on May 21, 2026
Reported Earnings • Feb 10Third quarter 2026 earnings released: EPS: ₹338 (vs ₹21.87 in 3Q 2025)Third quarter 2026 results: EPS: ₹338 (up from ₹21.87 in 3Q 2025). Revenue: ₹378.5m (up 262% from 3Q 2025). Net income: ₹136.6m (up ₹127.7m from 3Q 2025). Profit margin: 36% (up from 8.4% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Feb 03Polychem Limited to Report Q3, 2026 Results on Feb 09, 2026Polychem Limited announced that they will report Q3, 2026 results on Feb 09, 2026
Reported Earnings • Nov 13Second quarter 2026 earnings released: EPS: ₹17.73 (vs ₹11.45 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹17.73 (up from ₹11.45 loss in 2Q 2025). Revenue: ₹105.7m (up 43% from 2Q 2025). Net income: ₹7.17m (up ₹11.8m from 2Q 2025). Profit margin: 6.8% (up from net loss in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 32% per year, which means it is well ahead of earnings.
お知らせ • Nov 05Polychem Limited to Report Q2, 2026 Results on Nov 12, 2025Polychem Limited announced that they will report Q2, 2026 results on Nov 12, 2025
お知らせ • Jul 30Polychem Limited to Report Q1, 2026 Results on Aug 06, 2025Polychem Limited announced that they will report Q1, 2026 results on Aug 06, 2025
お知らせ • May 14Polychem Limited to Report Q4, 2026 Results on May 21, 2026Polychem Limited announced that they will report Q4, 2026 results on May 21, 2026
Valuation Update With 7 Day Price Move • Feb 26Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹2,285, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 168% over the past three years.
Reported Earnings • Feb 10Third quarter 2026 earnings released: EPS: ₹338 (vs ₹21.87 in 3Q 2025)Third quarter 2026 results: EPS: ₹338 (up from ₹21.87 in 3Q 2025). Revenue: ₹378.5m (up 262% from 3Q 2025). Net income: ₹136.6m (up ₹127.7m from 3Q 2025). Profit margin: 36% (up from 8.4% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Feb 03Polychem Limited to Report Q3, 2026 Results on Feb 09, 2026Polychem Limited announced that they will report Q3, 2026 results on Feb 09, 2026
Reported Earnings • Nov 13Second quarter 2026 earnings released: EPS: ₹17.73 (vs ₹11.45 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹17.73 (up from ₹11.45 loss in 2Q 2025). Revenue: ₹105.7m (up 43% from 2Q 2025). Net income: ₹7.17m (up ₹11.8m from 2Q 2025). Profit margin: 6.8% (up from net loss in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 32% per year, which means it is well ahead of earnings.
お知らせ • Nov 05Polychem Limited to Report Q2, 2026 Results on Nov 12, 2025Polychem Limited announced that they will report Q2, 2026 results on Nov 12, 2025
New Risk • Oct 14New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹885.3m (US$9.97m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹885.3m market cap, or US$9.97m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.3% average weekly change). Large one-off items impacting financial results. Revenue is less than US$5m (₹415m revenue, or US$4.7m).
New Risk • Aug 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.1% average weekly change). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (6.8% net profit margin). Revenue is less than US$5m (₹417m revenue, or US$4.8m). Market cap is less than US$100m (₹984.4m market cap, or US$11.3m).
お知らせ • Jul 30Polychem Limited to Report Q1, 2026 Results on Aug 06, 2025Polychem Limited announced that they will report Q1, 2026 results on Aug 06, 2025
Reported Earnings • Jul 23Full year 2025 earnings released: EPS: ₹70.06 (vs ₹178 in FY 2024)Full year 2025 results: EPS: ₹70.06 (down from ₹178 in FY 2024). Revenue: ₹416.5m (down 23% from FY 2024). Net income: ₹28.3m (down 61% from FY 2024). Profit margin: 6.8% (down from 13% in FY 2024). Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jul 17Polychem Limited, Annual General Meeting, Aug 12, 2025Polychem Limited, Annual General Meeting, Aug 12, 2025, at 11:00 Indian Standard Time.
New Risk • Jun 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.9% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (6.8% net profit margin). Revenue is less than US$5m (₹417m revenue, or US$4.9m). Market cap is less than US$100m (₹1.14b market cap, or US$13.3m).
Valuation Update With 7 Day Price Move • Jun 26Investor sentiment improves as stock rises 29%After last week's 29% share price gain to ₹2,522, the stock trades at a trailing P/E ratio of 36x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 303% over the past three years.
Declared Dividend • Jun 22Dividend reduced to ₹20.00Dividend of ₹20.00 is 33% lower than last year. Ex-date: 1st July 2025 Payment date: 31st July 2025 Dividend yield will be 1.0%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (29% earnings payout ratio) and cash flows (50% cash payout ratio). The dividend has increased by an average of 26% per year over the past 9 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 68% to shift the payout ratio to a potentially unsustainable range, which is more than the 1.6% EPS decline seen over the last 5 years.
New Risk • May 22New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 62% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹801.4m market cap, or US$9.36m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (6.8% net profit margin). Revenue is less than US$5m (₹417m revenue, or US$4.9m).
Reported Earnings • May 15Full year 2025 earnings released: EPS: ₹70.06 (vs ₹178 in FY 2024)Full year 2025 results: EPS: ₹70.06 (down from ₹178 in FY 2024). Revenue: ₹439.0m (down 19% from FY 2024). Net income: ₹28.3m (down 61% from FY 2024). Profit margin: 6.4% (down from 13% in FY 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • May 10Polychem Limited to Report Q4, 2025 Results on May 14, 2025Polychem Limited announced that they will report Q4, 2025 results on May 14, 2025
Board Change • Apr 01Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Director Anand Dalal was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Feb 28Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹1,910, the stock trades at a trailing P/E ratio of 18x. Average trailing P/E is 24x in the Chemicals industry in India. Total returns to shareholders of 228% over the past three years.
Buy Or Sell Opportunity • Feb 14Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.1% to ₹2,170. The fair value is estimated to be ₹2,793, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.1% over the last 3 years. Earnings per share has grown by 35%.
Reported Earnings • Feb 13Third quarter 2025 earnings released: EPS: ₹21.87 (vs ₹43.14 in 3Q 2024)Third quarter 2025 results: EPS: ₹21.87 (down from ₹43.14 in 3Q 2024). Revenue: ₹108.3m (down 18% from 3Q 2024). Net income: ₹8.84m (down 49% from 3Q 2024). Profit margin: 8.2% (down from 13% in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth.
New Risk • Feb 11New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹853.1m (US$9.84m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Market cap is less than US$10m (₹853.1m market cap, or US$9.84m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results.
お知らせ • Feb 03Polychem Limited to Report Q3, 2025 Results on Feb 11, 2025Polychem Limited announced that they will report Q3, 2025 results on Feb 11, 2025
Valuation Update With 7 Day Price Move • Nov 28Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₹2,525, the stock trades at a trailing P/E ratio of 19.8x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 447% over the past three years.
Reported Earnings • Nov 14Second quarter 2025 earnings released: ₹11.45 loss per share (vs ₹37.38 profit in 2Q 2024)Second quarter 2025 results: ₹11.45 loss per share (down from ₹37.38 profit in 2Q 2024). Revenue: ₹81.1m (down 33% from 2Q 2024). Net loss: ₹4.63m (down 131% from profit in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has increased by 67% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Nov 13Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹2,359, the stock trades at a trailing P/E ratio of 13.4x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 391% over the past three years.
お知らせ • Nov 06Polychem Limited to Report Q2, 2025 Results on Nov 13, 2024Polychem Limited announced that they will report Q2, 2025 results on Nov 13, 2024
Buy Or Sell Opportunity • Oct 08Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 4.7% to ₹3,062. The fair value is estimated to be ₹2,548, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 62%.
New Risk • Sep 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.2% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (₹1.24b market cap, or US$14.8m).
Valuation Update With 7 Day Price Move • Sep 18Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹3,538, the stock trades at a trailing P/E ratio of 20.1x. Average trailing P/E is 36x in the Chemicals industry in India. Total returns to shareholders of 599% over the past three years.
Buy Or Sell Opportunity • Sep 18Now 38% overvalued after recent price riseOver the last 90 days, the stock has risen 24% to ₹3,538. The fair value is estimated to be ₹2,566, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 62%.
お知らせ • Aug 29Polychem Limited Approves DividendPolychem Limited at its AGM held on August 29, 2024, approved to declare a dividend of INR 30.00 i.e (300%) per equity share of INR 10.00 each.
Reported Earnings • Aug 07Full year 2024 earnings released: EPS: ₹178 (vs ₹179 in FY 2023)Full year 2024 results: EPS: ₹178 (down from ₹179 in FY 2023). Revenue: ₹538.7m (up 5.1% from FY 2023). Net income: ₹72.0m (flat on FY 2023). Profit margin: 13% (in line with FY 2023). Over the last 3 years on average, earnings per share has increased by 71% per year and the company’s share price has also increased by 71% per year.
お知らせ • Aug 02+ 1 more updatePolychem Limited, Annual General Meeting, Aug 29, 2024Polychem Limited, Annual General Meeting, Aug 29, 2024, at 11:00 Indian Standard Time.
Buy Or Sell Opportunity • Jul 04Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 12% to ₹2,978. The fair value is estimated to be ₹2,466, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 71%.
New Risk • Jun 06New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 22% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Market cap is less than US$100m (₹1.12b market cap, or US$13.5m).
Buy Or Sell Opportunity • May 31Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 4.3% to ₹2,889. The fair value is estimated to be ₹2,406, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 71%.
Buy Or Sell Opportunity • May 15Now 21% overvaluedOver the last 90 days, the stock has fallen 3.0% to ₹2,894. The fair value is estimated to be ₹2,398, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 71%.
お知らせ • May 15Polychem Limited Proposes Dividend for the Financial Year Ended March 31, 2024Polychem Limited at its board meeting held on May 14, 2024, proposed payment of dividend of INR 30 per equity share of INR 10 each that is 300% on the Equity shares of the Company for the financial year ended 31st March, 2024, subject to the approval of shareholders at the upcoming Annual General Meeting.
お知らせ • May 08Polychem Limited to Report Q4, 2024 Results on May 14, 2024Polychem Limited announced that they will report Q4, 2024 results on May 14, 2024
Valuation Update With 7 Day Price Move • Apr 08Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹2,741, the stock trades at a trailing P/E ratio of 16.9x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 505% over the past three years.
Valuation Update With 7 Day Price Move • Mar 13Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹2,142, the stock trades at a trailing P/E ratio of 13.2x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 355% over the past three years.
Reported Earnings • Feb 10Third quarter 2024 earnings released: EPS: ₹43.14 (vs ₹38.35 in 3Q 2023)Third quarter 2024 results: EPS: ₹43.14 (up from ₹38.35 in 3Q 2023). Revenue: ₹137.5m (up 11% from 3Q 2023). Net income: ₹17.4m (up 13% from 3Q 2023). Profit margin: 13% (in line with 3Q 2023). Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has increased by 90% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Feb 03Polychem Limited to Report Q3, 2024 Results on Feb 09, 2024Polychem Limited announced that they will report Q3, 2024 results on Feb 09, 2024
Valuation Update With 7 Day Price Move • Dec 19Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹3,183, the stock trades at a trailing P/E ratio of 19.7x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 714% over the past three years.
Reported Earnings • Nov 09Second quarter 2024 earnings released: EPS: ₹37.38 (vs ₹71.44 in 2Q 2023)Second quarter 2024 results: EPS: ₹37.38 (down from ₹71.44 in 2Q 2023). Revenue: ₹124.1m (down 8.9% from 2Q 2023). Net income: ₹15.1m (down 48% from 2Q 2023). Profit margin: 12% (down from 21% in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 75% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 30Polychem Limited Approves to Declare A DividendPolychem Limited approved to declare a dividend of INR 20/- per equity share (i.e. 200%) of INR 10/- each.
Reported Earnings • Aug 09First quarter 2024 earnings released: EPS: ₹39.65 (vs ₹23.08 in 1Q 2023)First quarter 2024 results: EPS: ₹39.65 (up from ₹23.08 in 1Q 2023). Revenue: ₹142.4m (up 1.1% from 1Q 2023). Net income: ₹16.0m (up 72% from 1Q 2023). Profit margin: 11% (up from 6.6% in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 77% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth.
New Risk • Aug 07New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 102% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹612.8m market cap, or US$7.41m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.7% average weekly change). Large one-off items impacting financial results.
お知らせ • Aug 01Polychem Limited to Report Q1, 2024 Results on Aug 08, 2023Polychem Limited announced that they will report Q1, 2024 results on Aug 08, 2023
Valuation Update With 7 Day Price Move • Jun 30Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹1,335, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 240% over the past three years.
New Risk • Jun 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹510.8m market cap, or US$6.22m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.3% average weekly change).
Reported Earnings • May 19Full year 2023 earnings released: EPS: ₹179 (vs ₹12.53 in FY 2022)Full year 2023 results: EPS: ₹179 (up from ₹12.53 in FY 2022). Revenue: ₹568.5m (up 59% from FY 2022). Net income: ₹72.3m (up ₹67.2m from FY 2022). Profit margin: 13% (up from 1.4% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has increased by 67% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • May 18Polychem Limited Recommends Dividend for the Financial Year Ended 31 March 2023The board of directors of Polychem Limited at its meeting held on May 17, 2023, Payment of dividend of INR 20 per share of INR 10 each i.e 200% on the Equity shares of the Company for the financial year ended 31 March, 2023, subject to the approval of shareholders at the upcoming Annual General Meeting.
お知らせ • May 11Polychem Limited to Report Q4, 2023 Results on May 17, 2023Polychem Limited announced that they will report Q4, 2023 results on May 17, 2023
Valuation Update With 7 Day Price Move • May 11Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹1,123, the stock trades at a trailing P/E ratio of 7.5x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 292% over the past three years.
Valuation Update With 7 Day Price Move • Feb 15Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹977, the stock trades at a trailing P/E ratio of 6.5x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 126% over the past three years.
Buying Opportunity • Feb 14Now 20% undervaluedOver the last 90 days, the stock is up 3.5%. The fair value is estimated to be ₹1,228, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 17%.
Reported Earnings • Feb 09Third quarter 2023 earnings released: EPS: ₹38.35 (vs ₹4.37 loss in 3Q 2022)Third quarter 2023 results: EPS: ₹38.35 (up from ₹4.37 loss in 3Q 2022). Revenue: ₹127.7m (up 46% from 3Q 2022). Net income: ₹15.5m (up ₹17.3m from 3Q 2022). Profit margin: 12% (up from net loss in 3Q 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Feb 01Polychem Limited to Report Q3, 2023 Results on Feb 08, 2023Polychem Limited announced that they will report Q3, 2023 results on Feb 08, 2023
Reported Earnings • Nov 20Second quarter 2023 earnings released: EPS: ₹71.44 (vs ₹3.70 loss in 2Q 2022)Second quarter 2023 results: EPS: ₹71.44 (up from ₹3.70 loss in 2Q 2022). Revenue: ₹171.8m (up 108% from 2Q 2022). Net income: ₹28.9m (up ₹30.4m from 2Q 2022). Profit margin: 17% (up from net loss in 2Q 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 43% per year, which means it is well ahead of earnings.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 6 highly experienced directors. Woman Independent Non Executive Director Nirmala Mehendale was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Nov 05Polychem Limited to Report Q2, 2023 Results on Nov 14, 2022Polychem Limited announced that they will report Q2, 2023 results on Nov 14, 2022
お知らせ • Aug 31Polychem Limited Declares DividendPolychem Limited at its AGM held on 29 August 2022 declared a dividend of INR 3/- per equity share of INR 10/- each (i.e. 30%).
Valuation Update With 7 Day Price Move • Aug 30Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹969, the stock trades at a trailing P/E ratio of 33.6x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 241% over the past three years.
Valuation Update With 7 Day Price Move • Aug 16Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹737, the stock trades at a trailing P/E ratio of 25.6x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 145% over the past three years.
Reported Earnings • Aug 04Full year 2022 earnings released: EPS: ₹12.53 (vs ₹20.48 in FY 2021)Full year 2022 results: EPS: ₹12.53 (down from ₹20.48 in FY 2021). Revenue: ₹357.8m (up 45% from FY 2021). Net income: ₹5.06m (down 39% from FY 2021). Profit margin: 1.4% (down from 3.4% in FY 2021). Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 23% per year, which means it is well ahead of earnings.
お知らせ • Aug 04Polychem Limited, Annual General Meeting, Aug 29, 2022Polychem Limited, Annual General Meeting, Aug 29, 2022, at 11:00 Indian Standard Time. Agenda: To consider the audited Standalone financial statements of the Company for the financial year ended March 31, 2022, including the audited Standalone Balance Sheet as at March 31, 2022, the Statement of Profit and Loss and Cash Flow Statement, for the year ended on that date and the reports of the Board of Directors (the Board) and Auditors thereon; to discuss the audited consolidated financial statements of the Company for the financial year ended March 31, 2022, including the audited Consolidated Balance Sheet as at March 31, 2022, the Statement of Profit and Loss and Cash Flow Statement for the year ended on that date and the report of Auditors thereon; to declare dividend on equity shares; to reappoint statutory auditors; and to discuss other matters.
Valuation Update With 7 Day Price Move • Jun 27Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹640, the stock trades at a trailing P/E ratio of 51.1x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 140% over the past three years.
Valuation Update With 7 Day Price Move • Jun 07Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₹653, the stock trades at a trailing P/E ratio of 52.1x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 120% over the past three years.
お知らせ • May 27Polychem Limited Recommends DividendPolychem Limited announced Payment of dividend of INR 3.00 per share of INR 10 each i.e 30% on the Equity shares of the Company for the financial year ended 31st March, 2022, subject to the approval of shareholders at the ensuing 65th AGM.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 5 highly experienced directors. Woman Independent Non Executive Director Nirmala Mehendale was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Apr 18Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹709, the stock trades at a trailing P/E ratio of 77.9x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 151% over the past three years.
Reported Earnings • Feb 16Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: ₹4.37 loss per share (down from ₹13.94 profit in 3Q 2021). Revenue: ₹89.1m (up 29% from 3Q 2021). Net loss: ₹1.77m (down 131% from profit in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 31% per year, which means it is well ahead of earnings.
お知らせ • Feb 06Polychem Limited to Report Q3, 2022 Results on Feb 14, 2022Polychem Limited announced that they will report Q3, 2022 results on Feb 14, 2022
Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹555, the stock trades at a trailing P/E ratio of 20.2x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 49% over the past three years.
Reported Earnings • Jun 26Full year 2021 earnings released: EPS ₹20.48 (vs ₹75.89 in FY 2020)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹260.6m (down 29% from FY 2020). Net income: ₹8.27m (down 73% from FY 2020). Profit margin: 3.2% (down from 8.3% in FY 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 33% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Jun 24Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹802, the stock trades at a trailing P/E ratio of 32.7x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 183% over the past three years.
Valuation Update With 7 Day Price Move • Jun 05Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₹575, the stock trades at a trailing P/E ratio of 23.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 63% over the past three years.
Is New 90 Day High Low • Mar 10New 90-day high: ₹493The company is up 13% from its price of ₹437 on 10 December 2020. The Indian market is up 14% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Chemicals industry, which is up 9.0% over the same period.
Is New 90 Day High Low • Feb 11New 90-day high: ₹480The company is up 9.0% from its price of ₹440 on 13 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 16% over the same period.
Reported Earnings • Feb 06Third quarter 2021 earnings released: EPS ₹13.94 (vs ₹22.35 in 3Q 2020)The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹74.1m (down 14% from 3Q 2020). Net income: ₹5.63m (down 38% from 3Q 2020). Profit margin: 7.6% (down from 10% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.
お知らせ • Jan 25Polychem Limited to Report Q3, 2021 Results on Feb 05, 2021Polychem Limited announced that they will report Q3, 2021 results on Feb 05, 2021
Is New 90 Day High Low • Nov 17New 90-day low: ₹424The company is down 31% from its price of ₹616 on 19 August 2020. The Indian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period.
Valuation Update With 7 Day Price Move • Nov 06Market pulls back on stock over the past weekAfter last week's 16% share price decline to ₹475, the stock is trading at a trailing P/E ratio of 9.4x, down from the previous P/E ratio of 11.3x. This compares to an average P/E of 16x in the Chemicals industry in India. Total returns to shareholders over the past three years are 19%.
お知らせ • Jul 09Polychem Limited to Report Q4, 2020 Results on Jul 11, 2020Polychem Limited announced that they will report Q4, 2020 results on Jul 11, 2020